Impaired intestinal barrier function promotes the progression of various liver diseases, including cholestatic liver diseases. The close association of primary sclerosing cholangitis (PSC) with inflammatory bowel disease highlights the importance of the gut-liver axis. It has been reported that bile duct ligation (BDL)-induced liver fibrosis is significantly reduced in C/EBP homologous protein knockout (CHOP 2/2 ) mice. However, the underlying mechanisms remain unclear. In the current study, we demonstrate that BDL induces striking and acute hepatic endoplasmic reticulum (ER) stress responses after 1 day, which return to normal after 3 days. No significant hepatocyte apoptosis is detected 7-14 days following BDL. However, the inflammatory response is significantly increased after 7 days, which is similar to what we found in human PSC liver samples. BDLinduced loss of stemness in intestinal stem cells (ISCs), disruption of intestinal barrier function, bacterial translocation, activation of hepatic inflammation, M2 macrophage polarization and liver fibrosis are significantly reduced in CHOP 2/2 mice. In addition, intestinal organoids derived from CHOP 2/2 mice contain more and longer crypt structures than those from wildtype (WT) mice, which is consistent with the upregulation of stem cell markers (leucine-rich repeat-containing G-proteincoupled receptor 5, olfactomedin 4, and SRY [sex determining region Y]-box 9) and in vivo findings that CHOP 2/2 mice have longer villi and crypts as compared to WT mice. Similarly, mRNA levels of CD14, interleukin-1b, tumor necrosis factor-alpha, and monocyte chemotactic protein-1 are increased and stem cell proliferation is suppressed in the duodenum of patients with cirrhosis. Conclusion: Activation of ER stress and subsequent loss of stemness of ISCs plays a critical role in BDL-induced systemic inflammation and cholestatic liver injury. Modulation of the ER stress response represents a potential therapeutic strategy for cholestatic liver diseases as well as other inflammatory diseases. (HEPATOLOGY 2018;67:1441-1457).
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B ile duct obstruction is a major driving force that causes chronic cholestasis and eventually progressive liver fibrosis (LF) and cirrhosis regardless of different etiologies. (1) The accumulation of hydrophobic bile acids is believed to induce chronic inflammation and hepatocyte apoptosis. (2) Recent clinical studies indicate that disruption of intestinal barrier function and subsequent bacterial translocation also Abbreviations: ALP, alkaline phosphatatse; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ATF4, activating transcription factor 4; BDL, bile duct ligation; BrdU, 5-bromo-2 0 -deoxyuridine; CCL, C-C chemokine ligand; CFUs, colony-forming units; CHOP, C/EBP homologous protein; CK-19, cytokeratin-19; CXCL10, C-X-C motif chemokine 10; E-cad, E-cadherin; ER, endoplasmic reticulum; FGF15, fibroblast growth factor 15; FIZZ1, Resistin-like molecular alpha; GRP78, 78kDa glucose-regulated protein; H&E, hematoxylin-eosin; HIV, human immunodeficiency virus; HSCs, hepatic stellate cells; IBD, inflammatory bowel disease; IHC, immunohistochemical; IL, interleukin; ISCs, intestinal stem cells; KCs, Kupffer cells; LF, liver fibrosis; Lgr5, leucine-rich repeat-containing G-protein-coupled receptor 5; LOXL2, lysyl oxidase like 2; LPS, liposaccharide; MCP-1, monocyte chemotactic protein-1; MLN, mesenteric lymph node; OCLN, Occludin; Olfm4, olfactomedin 4; PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; SHP, small heterodimer partner; a-SMA, alpha smooth muscle actin; TBA, total bile acid; TG, thapsigargin; TGF-b, transforming growth factor beta; TLR, Toll like receptor; TNF-a, tumor necrosis factor-alpha; TUNEL, TdT-mediated dUTP nick-end labeling; UPR, unfolding protein response; WT, wild type; XBP-1s, X-box binding protein 1 spliced; ZO-1, zonula occuden-1.
contribute to cholestatic liver disease progression, such as primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and noncholestatic liver diseases by inducing hepatic inflammation. (3) It has been reported that PSC represents one of the most common extraintestinal manifestations of inflammatory bowel disease (IBD). (3) The close association between PSC and IBD highlights the importance of the gut-liver axis. (4) Furthermore, disruption of the intestinal barrier was not only observed in obstructive jaundice patients, but also in bile duct ligation (BDL) rodent models of cholestatic liver diseases. (5, 6) However, the underlying mechanisms remain largely unknown.
The intestinal epithelium represents the largest epithelial surface in our body. (7) The maintenance of intestinal epithelial integrity is not only important for nutrient absorption, but also critical to prevent invasion of the pathogenic microorganisms from the luminal contents. During the last decade, increasing evidence indicates that activation of the endoplasmic reticulum (ER) stress-mediated unfolding protein response (UPR) plays a central role in the maintenance of gastrointestinal mucosal homeostasis. (8) Extended activation of ER stress and dysregulated UPR induces the expression of the C/EBP homologous protein (CHOP), an apoptosis-promoting transcription factor, which has been identified as a major contributor to IBD because it induces epithelial cell death, impairs mucosal barrier function, and activates the inflammatory response. (8) (9) (10) Previous studies reported that ablation of CHOP alleviated dextran sulfate sodium-and trinitrobenzene sulfonic acid-induced experimental colitis. (11) (12) (13) We also reported that CHOP 2/2 mice were protected from human immunodeficiency virus (HIV) protease inhibitor (strong ER stress inducer)-induced disruption of intestinal barrier function and hepatic liver injury. (14, 15) The intestinal epithelium is highly proliferative and is organized into crypts and villi structures. All types of intestinal epithelia cells are differentiated from a common and constantly renewing leucine-rich repeat-containing G-protein coupled receptor 5 positive (Lgr5 1 ) intestinal stem cells (ISCs). (8, 16) Maintenance of normal physiological function of the ER is critical for cellular differentiation because a large number of specialized proteins require processing in the ER. ER stress has been linked to a loss of intestinal epithelial stemness. (17) It has been reported that BDL-induced cholestatic liver injury was attenuated in CHOP 2/2 mice through inhibition of hepatocyte apoptosis. (18) Although BDLinduced hepatocyte apoptosis was significantly reduced in CHOP 2/2 mice in 2 days, no significant difference between wild-type (WT) and CHOP 2/2 mice was observed after 2 weeks. (18) These results suggest that the other unidentified mechanisms may play more important roles in BDL-induced cholestatic liver injury than CHOP-mediated hepatocyte apoptosis. Based on our previous studies and studies from others, we hypothesize that ER stress-induced disruption of intestinal barrier function plays a critical role in cholestatic liver injury. Here, we used a combination of an in vivo 14-day BDL mouse model and in vitro cellular techniques to define the mechanisms underlying the CHOP deficiency-mediated protective effects against BDL-induced cholestatic liver injury. Our data reveal a critical role of CHOP in regulating the proliferation and differentiation of ISCs and intestinal epithelia homeostasis. ER stress-mediated rapid loss of intestinal epithelial stemness represents an important mechanism underlying BDL-induced disruption of gut-liver axis and cholestatic liver injury.
Materials and Methods

ANIMAL STUDIES
C57BL/6J wild-type (WT) mice and CHOP 2/2 mice (both male and female, 8-10 weeks old) were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed under a 12-hour light/12-hour dark cycle with free access to water and normal chow. BDL or sham operation was performed on WT and CHOP 2/2 mice as described for 1, 3, 5, 7, or 14 days. (19, 20) At the end of the experiment, the mice were sacrificed for further studies. All animal study protocols were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University (Richmond, VA).
HUMAN LIVER AND INTESTINE SAMPLES
De-identified frozen PSC patient liver tissues and normal human liver tissues were obtained through the Liver Tissue Cell Distribution System (Minneapolis, MN), which was funded by NIH Contract# HSN276 201200017C. After written informed consent, outpatients with compensated cirrhosis and age-and sexmatched healthy controls were prospectively recruited. Cirrhosis was diagnosed using FibroScan, liver biopsy, or by endoscopic or radiological evidence of portal hypertension in patients with chronic liver disease. None of the patients were abusing alcohol or illicit drugs or were on antibiotics or probiotics. Pinch biopsies from the second part of the duodenum were obtained during an upper endoscopy and were flash frozen in the endoscopy suite and stored at -808C until further analysis. This protocol was approved by the Institutional Review Board of the McGuire VA Medical Center in Richmond.
BACTERIAL TRANSLOCATION
Blood and mesenteric lymph nodes (MLNs) were harvested in sterile conditions. Blood and homogenized MLNs were diluted in series and plated on blood agar plates. After 72-hour incubation at 37 o C in aerobic conditions, colony-forming units (CFUs) were counted and calculated as described in a previous study. (21) 
ISOLATION OF INTESTINAL CRYPTS AND INTESTINAL ORGANOID CULTURE
Intestinal crypts and intestinal organoids were isolated and cultured as described. (22, 23) 
STATISTICAL ANALYSIS
Results are presented as the mean 6 SE and are from at least three independent experiments. One-way analysis of variance and posttest was performed to analyze the differences between multiple groups by GraphPad Prism (version 5; GraphPad Software Inc., San Diego, CA). P values of 0.05 were considered statistically significant.
Please see the Supporting Materials and Methods for more-detailed information for this section.
Results
BDL-INDUCED CHOLESTATIC LIVER INJURY WAS REDUCED IN CHOP
2/2 MICE To investigate whether CHOP deficiency had a protective effect against BDL-induced cholestatic liver injury, both age-and sex-matched WT and CHOP 2/2 mice were subjected to BDL or a sham operation for 14 days. Overall survival rate with BDL surgery in CHOP 2/2 mice was higher than that in WT mice (Supporting Fig. S1A ). BDL-induced increase of serum total bile acid (TBA), alkaline phosphatatse (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) was significantly reduced in CHOP 2/2 mice (Fig. 1A) . Histological analysis of liver sections indicated that BDL-induced cholestatic liver injury, characterized by inflammatory cell infiltration, bile duct overproliferation, collagen deposition, and fibrosis, was also significantly reduced in the absence of CHOP ( Results are represented as mean 6 SE (n 5 6-9). Statistical significance relative to the WT sham group, *P < 0.05; **P < 0.01; ***P < 0.001; relative to the WT BDL group, # P < 0.05; ## P < 0.01; ### P < 0.001. reduced in CHOP 2/2 mice (Supporting Fig. S1B -D), which was accompanied by a reduction of hepatic stellate cell (HSC) activation genes, including collagen I, alpha smooth muscle actin (a-SMA), lysyl oxidase like 2 (LOXL2), and Fibronectin (Fig. 1D ). In addition, BDL-induced increase of hepatic TBA and hydroxyproline levels in WT mice was also reduced in CHOP 2/2 mice (Fig. 1E,F ).
BDL-INDUCED HEPATIC INFLAMMATORY RESPONSES WERE INHIBITED IN CHOP 2/2 MICE
Profound inflammation is often associated with severe cholestatic liver injury. Consistent with hematoxylin-eosin (H&E) staining indicating massive inflammatory cell infiltration (Fig. 1B) , IHC staining of (CD)11b and F4/80 further showed that BDL significantly increased recruitment of CD11b 1 inflammatory cells into the periportal area, accompanied by an increased number of monocyte-derived macrophages (CD11b 1 /F4/80 1 ) in WT mice, which was reduced in CHOP 2/2 mice ( Fig. 2A ). Real-time PCR results further showed that mRNA levels of CD68 and F4/ 80, macrophage markers, were up-regulated by 10-and 8-fold, respectively, in WT BDL mice, but only 3-and 2-fold, respectively, in CHOP 2/2 BDL mice (Fig. 2B ). In addition, CD11b, a marker for recruited inflammatory cells, was also significantly elevated in WT BDL mice, but much less so in CHOP 2/2 BDL mice (Fig. 2B ). As expected, the proinflammatory chemokines and cytokines, including monocyte chemotactic protein-1 (MCP-1), C-X-C motif chemokine 10 (CXCL10), tumor necrosis factor-alpha (TNF-a), and interleukin (IL)-6, were markedly induced by BDL in WT mice, but not in CHOP 2/2 mice. These results indicate that BDL-induced hepatic inflammatory response was significantly reduced in the absence of CHOP (Fig. 2C,D) .
Macrophages have a remarkable plasticity and can differentiate into functionally diverse subtypes, for example, "classically activated" M1 and "alternatively activated" M2 macrophages. (24) Persistent activation of M2 macrophages promotes fibrosis progression. To further define the role of CHOP in promoting hepatic LF, we measured the mRNA levels of IL-10, an antiinflammatory cytokine mainly secreted by M2 macrophages, and several profibrotic cytokines and chemokines, such as transforming growth factor-beta (TGF-b), Resistin-like molecular alpha (Fizz-1), C-C chemokine ligand (CCL) 17, CCL22, and CCL24. BDL-induced up-regulation of IL-10, TGF-b, FIZZ-1, CCL17, CCL22, and CCL24 in WT mice was significantly reduced in CHOP 2/2 mice (Fig. 2E,F) .
ER STRESS-INDUCED HEPATOCYTE APOPTOSIS IS NOT THE MAJOR TRIGGER TO ACTIVATE HEPATIC INNATE IMMUNE RESPONSE IN 14-DAY BDL MOUSE MODEL
Cholestatic liver injury is associated with dysregulation of immune response and aberrant expression of inflammatory mediators induced by leaky-gut-derived bacteria and endogenous sterile danger signals released from apoptotic hepatocytes. (25) BDL induced rapid activation of the UPR in the liver, as indicated by a transient up-regulation of CHOP, activating transcription factor 4 (ATF4), and 78kDa glucose regulated protein (GRP78), after 1 day that returned to base level after 3 days (Fig. 3A) . In 14-day BDL mice, there was only a slight up-regulation of ATF4. Consistent with these findings and previous reports, no significant difference in hepatocyte apoptosis was observed between WT and CHOP 2/2 mice 14 days following BDL by TdT-mediated dUTP nick-end labeling (TUNEL) assay (Supporting Fig. S2A ). (18) Western blotting analysis and immunofluorescence staining of cleaved caspase-3 further confirmed our observations (Fig. 3B,C and Supplementary Fig. 2B ). However, mRNA levels of Toll-like receptor (TLR) 2, TLR4, CD14, IL-18, and IL-1b, key players involved in the bacterial infection-induced innate immunity activation, were not changed during the first few days, but markedly elevated 3-5 days after BDL, reaching peak levels after 7 days and persisting until 14 days (Fig. 3D,F) . Similarly, mRNA levels of TLR2, TLR4, CD14, IL-18, and IL-1b were also significantly elevated in the livers of PSC patients compared to normal controls, with most of them being associated with IBD and massive bacterial translocation (Fig 3E) . No significant change of the UPR genes was observed (Supporting Fig. S3 ). These findings suggest that BDL-induced activation of innate immunity and hepatic inflammation observed 14 days post-BDL is independent of ER stress-induced hepatocyte apoptosis. However, CHOP deficiency significantly ameliorated BDL-induced upregulation of TLR2, TLR4, CD14, IL-18, and IL-1b -/-mice were measured by qRT-PCR and normalized using HPRT1. Results are represented as mean 6 SE (n 5 6-9). Statistical significance relative to the WT sham group, *P < 0.05; **P < 0.01; ***P < 0.001; relative to the WT BDL group, # P < 0.05; ## P < 0.01. Results are represented as mean 6 SE from each group (n 5 5-9 for mice samples; n 5 10 for human samples). Statistical significance relative to the WT sham group or BDL 0 day group, *P < 0.05; **P < 0.01; ***P < 0.001; relative to the WT BDL group, # P < 0.05; ## P < 0.01; ### P < 0.001.
in the liver (Fig. 3F) , which indicates the involvement of gut bacterial translocation.
To further identify the specific hepatic cells involved in BDL-induced activation of the UPR and innate immunity, we isolated primary hepatocytes, Kupffer cells (KCs), cholangiocytes, and HSCs from WT BDL and sham control mice, and purity of the isolated cells was checked by real-time RT-PCR with specific hepatic cell markers, CK-19 for primary cholangiocytes, CYP1A2 for primary hepatocytes, f4/80 for KCs, and Desmin for HSCs (Supporting Fig. S4) . (26, 27) BDL induced CHOP expression in hepatocytes, not in other hepatic cells (Supporting Fig. S5A ). However, BDL significantly induced TLR2, TLR4, CD14, IL-18, and IL-1b in KCs and hepatocytes (Supporting Fig. S5B-F) .
CHOP DEFICIENCY PROTECTS AGAINST BDL-INDUCED DISRUPTION OF INTESTINAL BARRIER FUNCTION AND BACTERIAL TRANSLOCATION
Disruption of intestinal barrier integrity induces bacterial translocation into other organs and circulation and results in systemic inflammation. Our previous study showed that CHOP deficiency reduced HIV protease inhibitor-induced increase of intestinal permeability. (15) Similarly, the BDL-induced increase of gut permeability was also significantly reduced in CHOP 2/ 2 mice (Fig. 4A) . We further detected the bacteria in the MLNs, the first stop on the route of bacterial translocation, and in the blood. Significant bacterial translocation to the MLNs was first observed at 5 days and increased continuously until 14 days after BDL (Supporting Fig. S6A and Fig. 4B ), which was consistent with the time course of innate immunity activation in the liver (Fig. 3C) and intestine (Supporting Fig. S6B ). BDL-induced massive bacterial translocation in MLNs was significantly reduced in CHOP 2/2 mice (Fig. 4B ). In addition, colony counts of the bacteria from the MLNs of WT BDL mice were significantly higher than that of the bacteria level from the MLNs of CHOP 2/2 mice. Consistently, more bacteria were detected in the blood of WT BDL mice when compared to that of CHOP 2/2 mice (Fig. 4C) . Furthermore, H&E staining of intestines identified more inflammatory cell infiltration and lymphatic vessel dilation in WT mice than in CHOP 2/2 mice (Fig. 4D) . No obvious inflammatory cell infiltration was detected in the colon (Supporting Fig. S7A ). However, BDL significantly up-regulated IL-1b, TNF-a, and MCP-1 in both the intestine and colon, which was alleviated in CHOP 2/2 mice ( Fig. 4E and Supporting Fig. S7B ).
CHOP DEFICIENCY REDUCED BDL-INDUCED DISRUPTION OF TIGHT JUNCTION
Maintenance of the intestinal barrier integrity depends on a variety of mucosal structural components, which are tightly regulated in homeostasis. (28) The intercellular junctions are composed of the tight junction, adherens junction, and desmosome. The tight junction is the primary determinant of paracellular permeability, and the adherens junction and desmosomes provide the adhesive forces necessary for maintenance of cell-cell interaction. (28) To determine whether BDL-induced increase of intestinal permeability is caused by disruption of intercellular junctions, we first examined mRNA and protein expression levels of the tight junction proteins, zonula occuden-1 (ZO-1) and Occludin (OCLN), and the adherents junction protein, E-cadherin (E-cad). BDL did not affect mRNA and protein expression of ZO-1, OCLN, and E-cad (Fig. 5A,B) . However, impaired tight junction structure in the small intestinal epithelium was observed in WT BDL mice. BDL induced a mislocation of OCLN in WT mice, which was significantly improved in CHOP 2/2 BDL mice (Fig. 5C ). In the colon, BDL significantly suppressed both mRNA and protein expression of OCLN, ZO-1, and E-cad accompanied with the loss of tight junction structure in WT mice, but not in CHOP 2/2 mice (Supporting Fig. S8A-C) .
CHOP DEFICIENCY INHIBITS BDL-INDUCED INTESTINAL EPITHELIAL CELL APOPTOSIS
Our previous study demonstrated that ER stressinduced intestinal epithelial cell apoptosis was reduced in CHOP 2/2 mice. (15) To determine whether the CHOP deficiency-mediated protective effect against BDL-induced disruption of intestinal barrier function was attributed to an inhibition of cell apoptosis in the intestine, we did the TUNEL assay in small intestinal sections. Following BDL, intestinal epithelial cell apoptosis was significantly increased in WT mice (Fig.  5D ). Apoptotic cells located in the intestinal crypts were also observed, as indicated by black arrows. As expected, intestinal epithelial cell apoptosis was markedly inhibited in CHOP 2/2 mice. Similar results were also found in the colon (Supporting Fig. S8D ). Consistent with these findings, the proapoptotic mediator, CHOP, was significantly induced in WT BDL mice both in the small intestine and colon ( Fig. 5E and Supporting Fig. S8E ). BDL induced an up-regulation of spliced X-box binding protein-1 (XBP-1s), ATF4, and GRP78 in the intestine of both WT and CHOP 2/2 mice 14 days following BDL (Fig. 5F ), but not in the colon (Supporting Fig. S8F ). The overlapped time courses of activation of hepatic inflammation with ER stress-induced apoptosis in intestinal epithelium indicates that gut-derived bacteria may play a critical role in activation of innate immune response in the liver (Supporting Fig. S6B,C) .
CHOP DEFICIENCY RELIEVES BDL-INDUCED SUPPRESSION OF ISCs
The adult intestinal epithelium undergoes rapid renewal to replace the lost epithelial cells caused by toxic contents in the intestinal lumen. ISCs, a small population of cells that reside in the bottom of intestinal crypts, are responsible for daily self-renewal of intestinal epithelium. ISC-derived highly proliferative progenitor cells, transit-amplifying cells, differentiate into the absorptive or secretory epithelial lineage and further migrate to intestinal villi to maintain intestinal epithelium integrity. (29) Interestingly, the length of small intestine of CHOP 2/2 mice was longer than that of WT mice (Supporting Fig. S9 ). Histological analysis indicated that BDL significantly reduced the length of both villi and crypts in WT mice, but not in CHOP 2/2 mice (Figs. 4D and 6A ). These results suggest that BDL-induced CHOP expression may inhibit intestinal epithelium renewal by suppressing the proliferation and differentiation of ISCs. To further delineate the underlying mechanisms, the small intestinal crypts were isolated. The real-time PCR results indicate that BDL significantly activated expression of Lgr5 and olfactomedin (Olfm) 4 (Olfm4), the active ISC markers, 3 days after BDL. However, the expression levels of Lgr5 and Olfm4 were significantly inhibited 5-14 days after BDL in WT mice (Fig. 6B) . Interestingly, BDL had no significant effect on the expression of both Lgr5 and Olfm4 in CHOP 2/2 mice. Similarly, BDL-induced inhibition of Lgr5 in colon of WT mice was also reversed in CHOP 2/2 mice (Supporting Fig. S10A ). ISC self-renewal and maintenance of stemness highly depends on several signaling pathways in the stem cell niche, especially the Wnt/b-catenin pathway. c-Myc, a downstream signaling molecule in the Wnt/ b-catenin signaling pathway, is critical for the expression of a core set of Wnt-target genes. The mRNA level of c-Myc was down-regulated 5 days after BDL and persisted until 14 days in WT mice, but remained unchanged in CHOP 2/2 mice (Fig. 6C) . IHC results further demonstrated that c-Myc was markedly downregulated in both crypt base stem cells and crypt transient amplifying cells in BDL WT mice, but not in BDL CHOP 2/2 mice 14 days after BDL. In support of this finding, Ki67 was also examined. Its expression was significantly inhibited in 7-14 days after BDL in WT mice, but not in CHOP 2/2 mice (Fig. 6C,D) . Similar results were also found in the colon crypts (Supporting Fig. 10B,C) . To further examine the effect of BDL on intestinal epithelial cell turnover, 5-bromo-2 0 -deoxyuridine (BrdU) staining was performed. BDL induced a significant suppression of intestinal epithelium turnover in WT mice 7-14 days after BDL, but not in CHOP 2/2 mice (Fig. 6E) .
These results indicate that CHOP deficiency significantly relieved BDL-induced suppression of ISCs and intestinal epithelium turnover. It has been reported that activation of the UPR resulted in rapid loss of stemness. (17) Here, we found that BDL gradually induced CHOP, ATF4, and GRP78 activation starting from 5 days after BDL in intestinal crypts, which shared a similar time course of bacterial translocation and loss of stemness in intestinal crypt cells (Supporting Fig. S6A and Fig. 6B,F) . Although no significant difference in GRP78 expression between WT and CHOP 2/2 mice was observed, activation of ATF4 in intestinal crypts was inhibited in CHOP 2/2 mice (Fig. 6F) . These results suggest that CHOP is a major player in ER stress-induced suppression of ISC differentiation.
CHOP DEFICIENCY PROTECTS LIPOPOLYSACCHARIDE-AND ER STRESS-INDUCED LOSS OF STEMNESS IN CULTURED INTESTINAL EPITHELIAL ORGANOIDS
To delineate the role of CHOP on regulating ISC proliferation and differentiation, the organoids of primary intestinal epithelium from WT and CHOP 2/2 mice were cultured. Intestinal organoids were formed in 2 days and markedly expanded in 10 days (Fig. 7A) . The overall size of CHOP 2/2 intestinal organoids was significantly larger than that of WT organoids. In addition, intestinal organoids derived from CHOP 2/2 mice consisted of more crypts that were longer in structure than those from WT mice, which was consistent with the in vivo findings that CHOP 2/2 mice had a longer intestine with more intestinal villi and crypts when compared to WT mice (Supporting Fig.  S9 and Fig. 6A ).
To further determine the direct effect of bacterial toxin and ER stress activation on ISC differentiation, liposaccharide (LPS), and thapsigargin (TG), a known ER stress inducer, were added to the organoid culture medium at day 4 until day 10. No significant impact on both WT and CHOP 2/2 intestinal organoids was found for the first 2 days of treatment, but LPS induced a more differentiated epithelial cell shedding in the lumen-like structure of WT organoids (indicated by white arrows) and led to the destruction of WT organoid crypts (indicated by black arrows) after 4 days (Fig. 7B) . Strikingly, much less epithelial cell shedding and no destruction of crypts were observed in CHOP 2/2 organoids. Furthermore, TG rapidly inhibited intestinal organoid formation, as indicated by the smaller size and fewer crypts, 2 days after treatment in WT organoids, but had no significant effect on CHOP 2/2 organoids, even after 6-day treatment. In line with these findings, the mRNA level of the active stem cell marker, Lgr5, was significantly higher in CHOP 2/2 intestinal organoids (Fig 7C) . In addition, both LPS and TG significantly inhibited Ki67 expression in WT intestinal organoids, indicating reduced stem cell proliferation, but had no effect on CHOP 2/2 organoids (Fig. 7D) . In support of the real-time PCR results, immunofluorescence staining also showed decreased numbers of proliferative crypt cells, indicated by nuclear staining of proliferating cell nuclear antigen (White *), in LPS-and TG-treated WT organoids, but not in CHOP 2/2 organoids (Supporting Fig.  S11 ). Furthermore, both LPS and TG significantly induced CHOP expression in WT intestinal organoids, indicating the critical role of ER stress-induced CHOP expression in inhibiting ISC proliferation and differentiation (Fig. 7E) .
ACTIVATION OF ER STRESS AND INFLAMMATION IN THE DUODENUM OF PATIENTS WITH CIRRHOSIS
To further determine the clinical relevance of activation of intestinal ER stress and inflammatory response in human patients with cirrhosis, we examined the mRNA levels of CHOP, ATF4, GRP78, and XBP-1s in duodenal biopsy samples from 13 patients with cirrhosis and a similar number of age-/sex-matched healthy controls (cirrhosis 56 6 5 years old, controls 54 6 6 years old; 8 men in both groups). All patients with cirrhosis had active hepatitis C as the etiology of cirrhosis. Their mean Model for End-Stage Liver Disease score was 9 6 4 and all were Child class A. mRNA levels of CHOP, ATF4, and GRP78 were increased in the intestine of patients with cirrhosis (Supporting Fig. 12A ). Similar to our findings in BDL mice, intestinal mRNA levels of CD14, IL-1b, TNFa, and MCP-1 were also increased in patients with cirrhosis (Supporting Fig. 12B ). In addition, mRNA levels of LGR5, SRY (sex determining region Y)-box 9, c-Myc, and Ki67 were reduced, indicating the suppression of stem cell proliferation (Supporting Fig. 12C ).
Discussion
Bile duct obstruction plays a critical role in cholestatic liver disease progression, but the pathological mechanisms remain incompletely understood. The current study identifies a mechanism underlying BDL-induced cholestatic liver injury. Our results indicate that CHOP-mediated rapid loss of intestinal epithelial stemness and subsequent disruption of the gut-liver axis plays a crucial role in cholestatic liver disease progression.
CHOP is a key transcription factor responsible for ER stress-mediated cell injury and has been implicated in various pathological processes, including gastrointestinal disorders and cholestatic liver injury. (7, 10, 18, (30) (31) (32) (33) A study reported that CHOP 2/2 mice were protected from BDL-induced cholestatic liver injury without significant effect on hepatocyte apoptosis. (18) Another study with the CCl 4 -induced acute liver injury mouse model reported that CHOP was rapidly up-regulated after CCl 4 treatment. However, CHOP deficiency had no protective effect against CCl 4 -induced liver injury. (34) These studies suggest that the role of CHOP in BDL-induced cholestatic liver injury and acute liver injury may be different. In addition, CHOP was rapidly activated in the liver 1 day after BDL, but returned to basal levels after 3 days. However, the innate immune response was significantly activated 3 days after BDL. Furthermore, no significant difference of hepatocyte apoptosis were observed 14 days after -/-mice 3, 7, and 14 days after BDL were measured by qRT-PCR and normalized using HPRT1. Results are represented as mean 6 SE from each group (n 5 6-10). Statistical significance relative to the WT sham group or BDL 0-day group, *P < 0.05; **P < 0.01; relative to the WT BDL group, # P < 0.05; ## P < 0.01.
BDL between WT and CHOP 2/2 mice. All of these results suggest that CHOP-mediated hepatocyte apoptosis may only play a minimal role in BDLcholestatic liver injury.
Inflammation is a remarkable feature of the cholangiopathies. (25) To further identify the key mechanisms underlying the CHOP deficiency-mediated protective effect against BDL-cholestatic injury, we examined the (C-E) Relative mRNA levels of Lgr5, Ki67, and CHOP in crypt structures of intestinal organoids after 6-day treatment were measured by qRT-PCR and normalized using HPRT1. Results are represented as mean 6 SE from each group (n 5 3). Statistical significance relative to the WT organoids vehicle control group, *P < 0.05; **P < 0.01; relative to the WT organoids counterparts, # P < 0.05; ## P < 0.01; ### P < 0.001.
effect of CHOP on the gut-liver axis under cholestatic conditions. A fundamental function of the intestinal epithelium is to prevent the underlying immune system and the remainder of the body from harmful substances and pathogens. (28) Compromised intestinal barrier function has been associated with various human diseases, including liver diseases, such as PSC. (35) The intestinal epithelium is a polarized single-cell layer organized in crypts and villi, which is constantly exposed to various microbial toxins and ER stress inducers and has an extremely high turnover rate. (7) Excessive loss or reduced renewal of epithelial cells results in the disruption of epithelial layer integrity and an increase of intestinal permeability. In the BDL mouse model, the time courses of BDL-induced bacterial translocation, activation of intestinal ER stress, induction of intestinal epithelium apoptosis, suppression of intestinal turnover, and activation of hepatic inflammation, but not hepatocyte apoptosis, notably overlapped. BDL-induced liver injury and disruption of intestinal barrier function were all significantly reduced in CHOP 2/2 mice (Figs. 1, 2, 4 , and 5 and Supporting Figs. S1 and S2). By using both the in vivo BDL mouse model and the in vitro intestinal organoid culture model, we identified the important mechanisms of BDL-induced cholestatic liver injury. Furthermore, we also confirmed that our findings in BDL mice are clinically relevant to human patients with cirrhosis, even without cholestatic injury as the etiology (Supporting Figs. S3 and S11). Our data strongly support our hypothesis that ER stressmediated disruption of intestinal barrier function plays a critical role in cholestatic liver injury.
It has been reported that ER stress causes rapid loss of intestinal epithelial stemness through activation of the UPR. (17) Maintenance of self-renewal and proliferation of ISCs is critical for physiological function of the intestines, especially for postinjury intestinal repair. (29, 36) Our study demonstrates that BDLinduced activation of ER stress and the UPR, especially CHOP activation, is associated with a loss of intestinal epithelial stemness and further disruption of intestinal epithelium turnover. BDL had no direct effect on the expression of intestinal epithelial junction proteins, but increased intestinal epithelial cell apoptosis and suppressed epithelium turnover, which subsequently induced dislocation of OCLN and E-Cad, resulting in the disruption of intestinal barrier integrity. Most important, CHOP deficiency significantly increased proliferation of ISCs, as indicated by an increase of size and number of intestinal crypts in in vitro organoid culture (Fig. 7) . This was consistent with the in vivo findings that CHOP 2/2 mice had longer intestines and colons as well as more crypts and villi in the intestine (Figs. 4 and 6) . Furthermore, both LPS-and TG-induced loss of stemness was attenuated with CHOP deficiency (Fig. 7) .
In addition to the recently established correlation between PSC and IBD, intestinal barrier dysfunctioninduced bacterial translocation was suggested as a critical cause of end-stage liver diseases. (5) It has been reported that obstruction of bile flow causes overgrowth of intestinal bacteria and mucosal injury, which can lead to bacterial translocation and systemic infection. (37) It also has been reported that enterohepatic bacterial infections suppress the intestinal expression of fibroblast growth factor 15 (FGF15). The decrease in ileal FGF15 expression was associated with liver bacterial colonization and hepatobiliary pathophysiology. (38) We also found that BDL induced down-regulation of intestinal FGF15 and small heterodimer partner (SHP) expression, which was reversed in CHOP 2/2 mice (Supporting Fig. S13 ). In addition, the basal levels of intestinal and hepatic SHP mRNAs were higher in CHOP 2/2 mice than those in WT mice. Consistent with previously published studies, we also found that the inflammatory mediators were significantly upregulated in human PSC patient livers (Fig. 3E) . (39) Our results indicate that BDL induced bacterial translocation and massive infiltration of inflammatory cells, which was markedly reduced in the absence of CHOP.
Activation of KCs plays a pivotal role in the pathogenesis of LF. (40) Multiple lines of evidence from previous reports and our current study suggest that persistent inflammation further triggers macrophage phenotype transition from proinflammatory M1 (classically activated) macrophages to M2 (alternatively activated) macrophages. (41) (42) (43) M2 macrophages promote wound healing and damaged tissue regeneration through the production of a set of profibrotic cytokines and growth factors, including TGF-b, CCL-17, CCL-22, CCL-24, and Fizz-1. (24, 44) Macrophage depletion attenuates extracellular matrix deposition and ductular reaction in a mouse model of chronic cholangiopathies. (45) In addition, ER stress has been identified as a key regulator of macrophage differentiation. (46) Our study suggests that the protective effect of CHOP deficiency against BDL-induced hepatic inflammation and cholestatic injury was mainly attributed to the improvement of intestinal barrier function and inhibition of bacterial translocation and inflammation.
In summary, the current study demonstrates that ER stress-mediated intestinal barrier dysfunction represents a key event in BDL-induced cholestatic liver injury. ER stress-induced activation of CHOP suppresses ISC proliferation and intestinal epithelial cell renewal, which leads to disruption of intestinal barrier function, massive bacterial translocation, activation of KCs, and periportal inflammation and, eventually, results in fibrosis in the liver (Fig. 8) . Here, we have provided strong evidence that targeting CHOP represents a therapeutic strategy for cholestatic liver diseases as well as other inflammatory liver diseases.
